| Added by | mollevi |
|---|---|
| Group name | EquipeNB |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: OREGA Biotech; Ecully, France. IRCM, Institut de Recherche en Cancerologie de Montpellier; INSERM, U896; Universite Montpellier 1; CRLC Val d'Aurelle Paul Lamarque; Montpellier, France. IRCM, Institut de Recherche en Cancerologie de Montpellier; INSERM, U896; Universite Montpellier 1; CRLC Val d'Aurelle Paul Lamarque; Montpellier, France ; Departement d'Immunologie; Centre Hospitalier Regional Universitaire de Montpellier et Faculte de Medecine Universite Montpellier 1; Montpellier, France. Institut National de la Sante et de la Recherche Medicale (INSERM) UMR-S 976; Paris, France ; Universite Paris Diderot; Sorbonne Paris Cite; Laboratoire Immunologie Dermatologie & Oncologie; Paris, France. alt-title: Oncoimmunology accession-num: 25050201 |
| Tags | _EndnoteXML import |
| Date Added | 2018/11/14 - 12:04:32 |
| Date Modified | 2018/11/14 - 12:04:32 |
| Parent item | Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis |
Institut de Recherche en Cancérologie de
